123 related articles for article (PubMed ID: 23257520)
21. [Central nervous system involvement in connective tissue diseases].
Hirohata S
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Jun; 27(3):109-17. PubMed ID: 15291247
[TBL] [Abstract][Full Text] [Related]
22. Determination of Toll-like receptor-induced cytokine profiles in the blood and cerebrospinal fluid of Chikungunya patients.
Kashyap RS; Morey S; Bhullar S; Baheti N; Chandak N; Purohit H; Taori G; Daginawala H
Neuroimmunomodulation; 2014; 21(6):338-46. PubMed ID: 24776821
[TBL] [Abstract][Full Text] [Related]
23. [Recent aspects of Neuro-Behcet's disease].
Hirohata S
Brain Nerve; 2013 Nov; 65(11):1245-53. PubMed ID: 24200602
[TBL] [Abstract][Full Text] [Related]
24. Neurological manifestations of Behçet's disease in Japan: a study of 54 patients.
Ideguchi H; Suda A; Takeno M; Kirino Y; Ihata A; Ueda A; Ohno S; Baba Y; Kuroiwa Y; Ishigatsubo Y
J Neurol; 2010 Jun; 257(6):1012-20. PubMed ID: 20127350
[TBL] [Abstract][Full Text] [Related]
25. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
[TBL] [Abstract][Full Text] [Related]
26. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease.
Hamzaoui K; Hamzaoui A; Ghorbel I; Khanfir M; Houman H
Scand J Immunol; 2006 Dec; 64(6):655-60. PubMed ID: 17083622
[TBL] [Abstract][Full Text] [Related]
27. [Low-dose weekly methotrexate therapy for progressive neuro-Behçet's disease].
Suda H
Nihon Rinsho Meneki Gakkai Kaishi; 1999 Feb; 22(1):13-22. PubMed ID: 11185687
[TBL] [Abstract][Full Text] [Related]
28. Histopathology of central nervous system lesions in Behçet's disease.
Hirohata S
J Neurol Sci; 2008 Apr; 267(1-2):41-7. PubMed ID: 17976652
[TBL] [Abstract][Full Text] [Related]
29. VEGF and mRNA VEGF expression in CSF from Behçet's disease with neurological involvement.
Hamzaoui K; Ayed K; Hamza M; Hamzaoui A
J Neuroimmunol; 2009 Aug; 213(1-2):148-53. PubMed ID: 19493574
[TBL] [Abstract][Full Text] [Related]
30. Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behçet's disease.
Niino M; Ogata A; Kikuchi S; Tashiro K; Nishihira J
J Neurol Sci; 2000 Oct; 179(S 1-2):127-31. PubMed ID: 11054496
[TBL] [Abstract][Full Text] [Related]
31. Neurological complications of Behçet's syndrome.
Kidd DP
J Neurol; 2017 Oct; 264(10):2178-2183. PubMed ID: 28283819
[TBL] [Abstract][Full Text] [Related]
32. A pediatric patient with neuro-Behçet's disease.
Hatachi S; Nakazawa T; Morinobu A; Kasagi S; Kogata Y; Kageyama G; Kawano S; Koshiba M; Kumagai S
Mod Rheumatol; 2006; 16(5):321-3. PubMed ID: 17039316
[TBL] [Abstract][Full Text] [Related]
33. [A case of chronic progressive neuro-Behcet's disease with cerebellar ataxia and bulbar palsy preceding mucocutaneo-ocular symptoms].
Watanabe M; Kobayashi R; Hasegawa T; Yokoi S; Okada H; Okuda S
Rinsho Shinkeigaku; 2018 Feb; 58(2):105-110. PubMed ID: 29386494
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis.
Hirohata S; Kikuchi H; Sawada T; Nagafuchi H; Kuwana M; Takeno M; Ishigatsubo Y
Mod Rheumatol; 2012 Jun; 22(3):405-13. PubMed ID: 21935641
[TBL] [Abstract][Full Text] [Related]
35. Third complement component in cerebrospinal fluid in neuro-Behçet's syndrome. Conversion patterns by crossed immunoelectrophoresis.
Aoyama J; Inaba G; Shimizu T
J Neurol Sci; 1979 Apr; 41(2):183-90. PubMed ID: 86603
[TBL] [Abstract][Full Text] [Related]
36. [Leukotrienes and neurological diseases].
Irkeç C; Ercan S; Irkeç M
Mikrobiyol Bul; 1989 Oct; 23(4):342-7. PubMed ID: 2488942
[TBL] [Abstract][Full Text] [Related]
37. Increased serum interleukin-32 levels in patients with Behçet's disease.
Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal fluid and serum cytokine profiling to detect immune control of infectious and inflammatory neurological and psychiatric diseases.
Maxeiner HG; Marion Schneider E; Kurfiss ST; Brettschneider J; Tumani H; Bechter K
Cytokine; 2014 Sep; 69(1):62-7. PubMed ID: 25022963
[TBL] [Abstract][Full Text] [Related]
39. Cytokines do play a role in pathogenesis of tuberculous meningitis: A prospective study from a tertiary care center in India.
Sharma S; Goyal MK; Sharma K; Modi M; Sharma M; Khandelwal N; Prabhakar S; Sharma N; R S; Gairolla J; Jain A; Lal V
J Neurol Sci; 2017 Aug; 379():131-136. PubMed ID: 28716226
[TBL] [Abstract][Full Text] [Related]
40. Soluble Fas ligand levels in cerebrospinal fluid in neuro-Behçet's disease.
Aoyama-Hayashi E; Matsuda T; Ohya N; Tanaka C; Kongozi M; Kamo C; Hotta M; Ikejima H; Shiraishi M; Mizushima Y
Adv Exp Med Biol; 2003; 528():389-91. PubMed ID: 12918731
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
